Reaction Details Report a problem with these data
Target
Cathepsin K
Ligand
BDBM100293
Substrate
n/a
Meas. Tech.
In Vitro Inhibition Assay
Ki
0.8±0.0 nM
Citation
 Quibell, M; Watts, JP Piperazine compounds US Patent  US8501744 Publication Date 8/6/2013 
Target
Name:
Cathepsin K
Synonyms:
CATK_HUMAN | CTSK | CTSO | CTSO2 | Cathepsin O | Cathepsin O2 | Cathepsin X
Type:
Enzyme
Mol. Mass.:
36975.68
Organism:
Homo sapiens (Human)
Description:
P43235
Residue:
329
Sequence:
MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM
  
Inhibitor
Name:
BDBM100293
Synonyms:
US8501744, 12
Type:
Small organic molecule
Emp. Form.:
C25H34F2N4O4
Mol. Mass.:
492.5587
SMILES:
CC(C)C[C@H](NC(=O)c1ccc(cc1)N1CCN(C)CC1)C(=O)N1C[C@H](C(F)F)[C@H]2OCC(=O)[C@@H]12 |r|
Structure:
Search PDB for entries with ligand similarity: